Hit enter to search or ESC to close
Home
About
Company Overview
Our Partners
Leadership Team
Board of Directors
Scientific Advisory Board
Pipeline
Pipeline of Compositions
Expansion Repeat Disorders
Myotonic Dystrophy Type 1
Myotonic Dystrophy Type 2
Platform
Overview
Publications
Newsroom
Contact
General Inquiries
Partnership Inquiries
Career Opportunities
News Alerts
In the News
Expansion into TNBC – BioCentury
By
Expansion Therapeutics
February 21, 2019
February 25th, 2019
No Comments
Expansion into TNBC – BioCentury
Love
0
Share
Tweet
Share
Home
About
Company Overview
Our Partners
Leadership Team
Board of Directors
Scientific Advisory Board
Pipeline
Pipeline of Compositions
Expansion Repeat Disorders
Myotonic Dystrophy Type 1
Myotonic Dystrophy Type 2
Platform
Overview
Publications
Newsroom
Contact
General Inquiries
Partnership Inquiries
Career Opportunities
News Alerts
Recent News and Insights
Scientists Take Aim at Disease-Causing RNAs Using Small-Molecule Drugs – The Scientist
April 1, 2019
Expansion Therapeutics Named a 2019 Xconomy Awards San Diego Finalist
March 27, 2019
Perspectives on Targeting RNA with Small Molecules to Capture Opportunities at the Intersection of Chemistry, Biology, and Medicine – JACS
March 22, 2019
